Austin-based medical device company Luminex said Monday it has laid off more than 50 employees as part of a restructuring plan related to its acquisition of Nanosphere last year.
Company spokeswoman Christine Valle said the reorganization is “companywide” and impacted each of their three North American facilities, including Austin.
She said the layoffs affected approximately 50 people, or about 5 percent of the workforce.
Luminex has a presence in seven cities outside of its Austin headquarters, including Hong Kong and Toronto.
Luminex develops biological testing systems. The company’s testing systems allow a tiny sample of blood to be tested for dozens of biological markers. It can be used for gene-based research and diagnostics.
In a securities filing Luminex said it conducted a reorganization in December “to facilitate the integration of Nanosphere and to better focus on our core business.”
Nanosphere, which Luminex bought in June for $77 million, makes diagnostic tools that allow for quick and accurate detection of infections.
This restructuring includes the layoffs and “a reallocation of responsibilities within the R&D organization and a significant reduction of biodefense efforts,” Luminex said in a securities filing.
The company said it will recognize a charge of $2.5 million in its fourth quarter related to these activities and expects total savings of $9 million annually.
This story was updated at 6:15 p.m. to include comments from a Luminex spokeswoman.
News on Open Source is free and unlimited. Access to the rest of 512tech.com comes with an American-Statesman digital subscription, which also includes myStatesman.com and the ePaper edition. Subscribe at statesman.com/subscribe.